Novartis Q4 Profit Surges, Above Estimates; Sees Growth In FY18; Stock Up
Shares of Novartis AG were gaining around 2 percent in the morning trading after the Swiss drug major reported Wednesday that its fourth-quarter profit more-than-doubled with higher sales and the absence of prior year's charge. Looking ahead, for fiscal 2018, the company expects net sales to grow low to mid single digit, and core operating income to grow mid to high single digit.
Source: RTTNews